In the latest issue of CHEManager, Juan Rigall, Managing Director of Santiago Advisors, examines the “Innovation Pathway 2030” and explores the question of how Germany can sustainably strengthen its position as a location for the chemical and pharmaceutical industries.

The focus is on the key levers for future-proof innovation capability against the backdrop of the site’s structural challenges. These include, among others, the transfer of excellent research into industrial application, global innovation networks, clusters and ecosystems, the strategic use of domain knowledge, and an innovation-friendly corporate culture.

The central message: Germany continues to have strong fundamentals – but only through decisive and coordinated action by companies, policymakers, and research institutions can the long-term competitiveness of the chemical and pharmaceutical industries be secured.

The print edition is available now.

The interview can be accessed online on the CHEManagers  website and is also available directly here as a PDF download.

Would you like to better understand the Innovation Pathway 2030 and its strategic implications for your company?

Santiago Advisors supports decision-makers in the chemical and life sciences industries in developing robust responses to disruptive market changes – analytically sound, collaborative, and execution-driven. We would be happy to connect with you for an informal discussion.